Th1 and Th17 mucosal immune responses elicited by nasally inoculation in mice with virulence factors of Mycoplasma hyopneumoniae.
Intramuscular immunization
Intranasal immunization
Mycoplasma hyopneumoniae
NADH oxidase
Nicotinamide Adenine Dinucleotide-Dependent (NADH) oxidoreductase
Journal
Microbial pathogenesis
ISSN: 1096-1208
Titre abrégé: Microb Pathog
Pays: England
ID NLM: 8606191
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
received:
01
06
2022
revised:
08
09
2022
accepted:
10
09
2022
pubmed:
19
9
2022
medline:
28
10
2022
entrez:
18
9
2022
Statut:
ppublish
Résumé
Nicotinamide Adenine Dinucleotide-Dependent (NADH) flavin oxidoreductase and NADH oxidase (NOX) are important virulence factors of Mycoplasma hyopneumoniae (Mhp), which are devoted to the function of adhesion, oxidative stress damage and apoptosis to host cells in our previous studies. Here, immune responses of NADH flavin oxidoreductase (NFOR) and NOX in mice and immune efficacy inoculated with intramuscular (IM), intranasal (IN), intramuscular unite intranasal (IM + IN) approaches were evaluated and compared. Cellular immunity levels, systemic immune and local mucosal immune responses were investigated by indirect enzyme-linked immunosorbent assay (iELISA) and quantitative reverse transcription PCR (qRT-PCR). Mice inoculated with NFOR and NOX by IM and IN or IM + IN could induce obvious secretion of specific immunoglobulin G (IgG) and secretory immunoglobulin A antibodies (sIgA) compared to those in negative control group. IM + IN inoculation resulted in systemic and local mucosal immune responses that were strongly produced. Moreover, Mhp NFOR and NOX could activate local mucosal immune responses mediated by Th1 and Th17 cells by IN. Our finding supported the notion that IM + IN was an effective immunization route for Mhp, which lays a foundation for more effective prevention of Mhp, and provides theoretical basis for the development of new subunit vaccines of Mhp.
Identifiants
pubmed: 36116609
pii: S0882-4010(22)00392-8
doi: 10.1016/j.micpath.2022.105779
pii:
doi:
Substances chimiques
NAD
0U46U6E8UK
Virulence Factors
0
FMN Reductase
EC 1.5.1.38
Bacterial Vaccines
0
Immunoglobulin G
0
Vaccines, Subunit
0
Immunoglobulin A, Secretory
0
Flavins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
105779Informations de copyright
Copyright © 2022 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Xing Xie reports administrative support and equipment, drugs, or supplies were provided by National Natural Science Foundation of China. Xing Xie reports equipment, drugs, or supplies and writing assistance were provided by Jiangsu Agricultural Science and Technology Independent Innovation Fund. Xing Xie reports equipment, drugs, or supplies was provided by the Independent Research Project Program of Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base, Ministry of Science and Technology, China. Fei Hao reports equipment, drugs, or supplies was provided by the Independent Research Project Program of Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base, Ministry of Science and Technology, China. Zhenzhen Zhang reports equipment, drugs, or supplies was provided by National Natural Science Foundation of China. The authors declare that there is no conflict of interest.